Anticoagulation Clinical Trial
Official title:
Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France - Cross-sectional Study
The present study will be conducted to assess the following research questions in real-life
conditions in France:
What are the patient and disease characteristics, comorbidities and treatment history in
NVAF patients initiating a new Anticoagulant (AC) treatment, according to treatment
currently available and prescribed (apixaban, other NOACs, VKAs), and are the AC-naive
patient profiles different from one treatment pattern to another when initiating a new AC
treatment?
What are the HCP's reasons for discontinuing the previous AC strategy for initiating and
choosing the newly initiated AC treatment in NVAF patients?
What are the conditions of newly-initiated apixaban prescriptions in NVAF patients:
prescriber, proportion of naïve/experienced patients, daily dosage and number of daily
doses?
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02705976 -
Prospective Trial of a Validated Algorithm for Warfarin Dosing
|
N/A | |
| Active, not recruiting |
NCT04139525 -
Comparison of Citrate and Heparin Anticoagulation During Hemodialysis With MCO PES-PVP (Theranova) Membrane
|
N/A | |
| Completed |
NCT01907048 -
Patient and Physician Knowledge of Key Safety Messages
|
||
| Recruiting |
NCT03419923 -
Three Anticoagulation Strategies for Hemodialysis in Patients at Risk of Hemorrhage
|
N/A | |
| Completed |
NCT03575936 -
Enhanced Pharmacist-Managed Anticoagulation Service in a University-based Family Medicine Clinic
|
N/A | |
| Recruiting |
NCT01314235 -
Influence of Clonidine on Thrombozytes of Blood of Patients Under Anticoagulation Therapy With ASS and Clopidogrel
|
N/A | |
| Withdrawn |
NCT04059965 -
AntiCoagulation Tracking InterVention and Evaluation
|
N/A | |
| Recruiting |
NCT02987192 -
Minimally Invasive Lumbar Aneasthesia Used for Cesarean Section
|
N/A | |
| Completed |
NCT01477528 -
Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)
|
||
| Recruiting |
NCT04405232 -
Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK
|
||
| Recruiting |
NCT02761941 -
Excessive Warfarin Anticoagulation - Causes and Consequences
|
N/A | |
| Completed |
NCT02392104 -
Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service
|
N/A | |
| Completed |
NCT01884337 -
Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery
|
Phase 4 | |
| Recruiting |
NCT03473132 -
Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC)
|
Phase 4 | |
| Enrolling by invitation |
NCT05305612 -
Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions
|
Phase 4 | |
| Completed |
NCT03662594 -
Growth of High-Quality Oxides on The Inner Surface of ECMO Circuit by ALD to Reduce Thrombus Formation
|
N/A | |
| Active, not recruiting |
NCT03910933 -
Electronic KIDCLOT Interactive Thrombosis/Thrombophilia Education; A Quality Assurance Initiative
|
||
| Completed |
NCT02492828 -
Adherence of Apixaban and Warfarin in Patients With Arterial Fibrillation in Real-world Setting in Sweden
|
N/A | |
| Completed |
NCT03684395 -
Accessibility to New Drugs Versus SOC in Sweden
|
||
| Completed |
NCT01124058 -
Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial
|
Phase 1 |